The Globe and Mail reports in its Friday, Jan. 9, edition that Raymond James analyst Steve Hansen has upgraded Ag Growth International to "outperform" from "market perform." The Globe's David Leeder writes that Mr. Hansen continues to target the shares at $52. Analysts on average target the shares at $35.50. Mr. Hansen says in a note: "After an extended filing delay, Ag Growth International (AGI) reported 3Q25 adj. EBITDA of $71-million (up 4 per cent year-over-year), handily ahead of both the Street and RJL estimates of $65-million and $61-million, respectively, with the bulk of the upside (vs. our estimate) attributable to better-than-expected top line (U.S. and international) and consolidated margin. Despite the beat, management issued a cautious 4Q25 outlook, calling for 'lower' adj. EBITDA (both sequential and year-over-year) due to challenging market conditions, negative mix and notably higher SG&A. Still, the clear surprise in the report was the lack of any discernible 'impact' on the company's financials associated with the filing delay, suggesting the whole event introduced extraordinary concern over something fairly inconsequential. In hindsight, the whole situation now looks like a 'tempest in a teapot.'"